Cargando…
Flurbiprofen suppresses the inflammation, proliferation, invasion and migration of colorectal cancer cells via COX2
Colorectal cancer is an aggressive disease with a poor prognosis and low survival rate at the advanced stage, therefore new innovative targets are urgently required. Flurbiprofen has been reported to exhibit therapeutic effects in other types of cancer, such as esophageal cancer, breast cancer and c...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471702/ https://www.ncbi.nlm.nih.gov/pubmed/32934701 http://dx.doi.org/10.3892/ol.2020.11993 |